329 related articles for article (PubMed ID: 29149020)
1. Role of Transforming Growth Factor β in Uterine Fibroid Biology.
Ciebiera M; Włodarczyk M; Wrzosek M; Męczekalski B; Nowicka G; Łukaszuk K; Ciebiera M; Słabuszewska-Jóźwiak A; Jakiel G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149020
[TBL] [Abstract][Full Text] [Related]
2. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids.
Ciebiera M; Włodarczyk M; Wrzosek M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
Fertil Steril; 2018 Mar; 109(3):501-507.e2. PubMed ID: 29525690
[TBL] [Abstract][Full Text] [Related]
3. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.
Ciebiera M; Włodarczyk M; Zgliczyńska M; Łukaszuk K; Męczekalski B; Kobierzycki C; Łoziński T; Jakiel G
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518097
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
6. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
7. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
8. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
10. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide activated TLR4/NF-κB signaling pathway of fibroblasts from uterine fibroids.
Guo J; Zheng L; Chen L; Luo N; Yang W; Qu X; Liu M; Cheng Z
Int J Clin Exp Pathol; 2015; 8(9):10014-25. PubMed ID: 26617709
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
13. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract][Full Text] [Related]
14. Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance.
Ciebiera M; Ali M; Zgliczyńska M; Skrzypczak M; Al-Hendy A
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752274
[TBL] [Abstract][Full Text] [Related]
15. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women.
Malik M; Norian J; McCarthy-Keith D; Britten J; Catherino WH
Semin Reprod Med; 2010 May; 28(3):169-79. PubMed ID: 20414841
[TBL] [Abstract][Full Text] [Related]
16. [Molecular and cytogenetic evidence for the development of fibroids].
Knapp P; Chabowski A
Postepy Hig Med Dosw (Online); 2012 Jan; 66():23-32. PubMed ID: 22371402
[TBL] [Abstract][Full Text] [Related]
17. Short-term tetrabromobisphenol A exposure promotes fibrosis of human uterine fibroid cells in a 3D culture system through TGF-beta signaling.
Liu J; Yu L; Castro L; Yan Y; Clayton NP; Bushel P; Flagler ND; Scappini E; Dixon D
FASEB J; 2022 Feb; 36(2):e22101. PubMed ID: 35032343
[TBL] [Abstract][Full Text] [Related]
18. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
20. Uterine fibroids: clinical manifestations and contemporary management.
Doherty L; Mutlu L; Sinclair D; Taylor H
Reprod Sci; 2014 Sep; 21(9):1067-92. PubMed ID: 24819877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
